Proc. roy. Soc. Med. Volume 66 June 1973 14 Central nervous stimuli related to reproductive function are mediated by hypothalamic factors (releasing hormones) which are transported by hypophyseal portal vessels to the anterior pituitary gland. One such factor -gonadotrophin releasing hormonehas been extracted from hypothalamic tissue and characterized. It is potent, as is its synthetic form (LH/FSH-RH), in the release of both LH and FSH from the anterior pituitary and can therefore be used as a test of pituitary function (Schally et al. 1971) . A potential use of LH/FSH-RH lies in the treatment of anovulatory sterility (Akande et al. 1972 , Newton & Collins 1972 . However, for ovulation to be achieved following its administration two conditions require to be fulfilled. First, the anterior pituitary must be capable of a vigorous gonadotrophic response to a preliminary test dose of LH/FSH-RH (Keller 1972) . Secondly, the ovaries should contain ripe follicles; this state can be assessed by measuring plasma cestrogen levels which are normally raised prior to the preovulatory surge of gonadotrophins .
LH/FSH-RH may also be useful in the treatment of certain dysfunctions of spermatogenesis. Furthermore, when analogues of the releasing hormone become available they may provide easier and safer methods of long-term contraception than are now possible. Shearman & Smith (1972) and those in 14 cases recently seen in the Chelsea Hospital for Women. In each series the absence of the very common emotional causes of hypothalamic suppression suggests that these are less likely to promote galactorrhcea than other causes more profoundly affecting hypothalamic activity. When an apparent clear-cut cause for galactorrhoea is present, however, such as oral contraceptives, it must never be assumed that there is not some other possible cause present, notably a pituitary tumour. Several cases are on record in which a pituitary tumour was present as well as some other precipitating cause, such as pregnancy or the pill (Young et al. 1967 , Macleod et al. 1970 , Hughes et al. 1972 ). Galactorrhoea is not invariably associated with secondary amenorrhcea, as was the case in 3 patients recently seen at the Chelsea Hospital for Women; one of these has recently become pregnant without treatment. If the patient is anxious for a pregnancy, treatment to stimulate ovulation with clomiphene and/ or human gonadotrophin has a chance of success which is comparable with that achieved in our patients with post-pill amenorrheea without galactorrhcea who had a pregnancy rate of 40%. If a pregnancy is not desired, there is a possibility of spontaneous cure, as happened in one of our own patients. If galactorrhcea is really troublesome, success has been reported with L-Dopa, 0.5 g given six-hourly with cessation of galactorr-hcEa in 11 of 14 patients (Turkington 1972) . Of particular interest is the report of successful treatment of galactorrhoea with the ergot alkaloid, bromergocryptine (Lutterbeck et al. 1971 , Besser et al. 1972 ). This drug given in doses varying between 3 and 9 mg/day was successful in suppressing galactorrhcea and allowing resumption of menstruation.
